Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for cancer pain
ACTRN12615001336572Phase 2Terminated
- Sponsor
- Palliative Care Clinical Studies Collaborative
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexamethasone in cancer pain, sponsored by Palliative Care Clinical Studies Collaborative. Primary endpoints: Feasibility co-primary endpoint 1 and Feasibility co-primary endpoint 2. Started Feb 2016; status: terminated.
02
Drugs
dexamethasone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ACTRN12615001336572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001336572.